TY - JOUR
T1 - Author Correction
T2 - Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)
AU - Al‑Darraji, Ahmed
AU - Donahue, Renée R.
AU - Tripathi, Himi
AU - Peng, Hsuan
AU - Levitan, Bryana M.
AU - Chelvarajan, Lakshman
AU - Haydar, Dalia
AU - Gao, Erhe
AU - Henson, David
AU - Gensel, John C.
AU - Feola, David J.
AU - Venditto, Vincent J.
AU - Abdel‑Latif, Ahmed
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - The Acknowledgements section in this Article is incomplete. “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” should read: “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).”.
AB - The Acknowledgements section in this Article is incomplete. “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” should read: “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).”.
UR - http://www.scopus.com/inward/record.url?scp=85102676635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102676635&partnerID=8YFLogxK
U2 - 10.1038/s41598-021-85720-6
DO - 10.1038/s41598-021-85720-6
M3 - Comment/debate
C2 - 33731792
AN - SCOPUS:85102676635
SN - 2045-2322
VL - 11
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 6654
ER -